Cargando…

The Efficacy of GnRHa Alone or in Combination with rhGH for the Treatment of Chinese Children with Central Precocious Puberty

The addition of recombinant human growth hormone (rhGH) to GnRH agonist (GnRHa) to treat central precocious puberty (CPP) is controversial. We systemically reviewed and evaluated the efficacy and safety of the rhGH and GnRHa adjunctive therapy in Chinese children with CPP and assessed the influence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Mengjie, Zhang, Youjie, Lan, Dan, Hill, Jennifer W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829831/ https://www.ncbi.nlm.nih.gov/pubmed/27072597 http://dx.doi.org/10.1038/srep24259

Ejemplares similares

Treatment of central precocious puberty using low dose GnRH analogs (GnRHa)
por: Jahagirdar, Rahul, et al.
Publicado: (2015)

A single sample GnRHa stimulation test in the diagnosis of precocious puberty
por: Yazdani, Parvin, et al.
Publicado: (2012)

Experience with the once-yearly histrelin (GnRHa) subcutaneous implant in the treatment of central precocious puberty
por: Lewis, Katherine A, et al.
Publicado: (2009)

GnRHa/Stanozolol Combined Therapy Maintains Normal Bone Growth in Central Precocious Puberty
por: Zhu, Shunye, et al.
Publicado: (2021)

Response of South Indian girls with central precocious puberty to gonadotrophin analogue (GnRHa) therapy – a single center experience
por: Selvaraj, Meghana, et al.
Publicado: (2021)

Fertility preservation and GnRHa for chemotherapy: debate
por: Blumenfeld, Zeev
Publicado: (2014)

GnRHa trigger—the story of the ugly duckling
por: Humaidan, Peter, et al.
Publicado: (2023)

Growth, bone maturation and ovarian size in girls with early and fast puberty (EFP) and effects of three years treatment with GnRH analogue (GnRHa)
por: Alaaraj, Nada, et al.
Publicado: (2021)

The Luteal Phase after GnRHa Trigger-Understanding An Enigma
por: Leth-Moller, Kathrine, et al.
Publicado: (2014)

Central Precocious Puberty and Response to GnRHa Therapy in Children with Cerebral Palsy and Moderate to Severe Motor Impairment: Data from a Longitudinal, Case-Control, Multicentre, Italian Study
por: Bruzzi, Patrizia, et al.
Publicado: (2017)

Long-term effects and significant adverse drug reactions (ADRs) associated with the use of gonadotropin-releasing hormone analogs (GnRHa) for central precocious puberty: a brief review of literature
por: De Sanctis, Vincenzo, et al.
Publicado: (2019)

Pituitary suppression with a GnRHa short protocol in an alternate day schedule associated with rhCG microdoses
por: Rodrigues, Rosane S., et al.
Publicado: (2014)

Challenges in monitoring GnRH analog treatment in central precocious puberty
por: Latronico, Ana Claudia
Publicado: (2020)

Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone
por: Agarwal, Sanjay K., et al.
Publicado: (2015)

Development of Hip Bone Geometry in Transgender Adolescents Resembles the Experienced Gender if GnRHa Treatment Is Started in Early, but Not Late, Puberty
por: van der Loos, Maria A T C, et al.
Publicado: (2021)

GnRH test for the diagnosis of central precocious puberty: is it time to revisit the protocol ?
por: Sodero, Giorgio, et al.
Publicado: (2023)

Benefits from the first year of GnRHa therapy in boys with idiopathic central precocious puberty when initiating treatment after age 9 years: findings from a real-world retrospective study
por: Ni, Ming-ming, et al.
Publicado: (2022)

Comparison of Clinical Efficacy between a Single Administration of Long-Acting Gonadotrophin-Releasing Hormone Agonist (GnRHa) and Daily Administrations of Short-Acting GnRHa in In Vitro Fertilization-Embryo Transfer Cycles
por: Cheon, Kang Woo, et al.
Publicado: (2008)

Perspectives on the co-treatment with GnRHa in female patients undergoing hematopoietic stem cell transplantation
por: Cima, Luminita Nicoleta, et al.
Publicado: (2017)

Curative GnRHa treatment has an unexpected repressive effect on Sertoli cell specific genes
por: Gegenschatz-Schmid, Katharina, et al.
Publicado: (2018)

Empty Follicle Syndrome Following GnRHa Trigger in PCOS Patients Undergoing IVF Cycles
por: Deepika, Krishna, et al.
Publicado: (2018)

GnRHa Before Single-Port Laparoscopic Hysterectomy in a Large Barrel-Shaped Uterus
por: Torng, Pao-Ling, et al.
Publicado: (2019)

Testicular expression of long non–coding RNAs is affected by curative GnRHa treatment of cryptorchidism
por: Hadziselimovic, Faruk, et al.
Publicado: (2019)

Evaluating the Efficacy of Treatment with a GnRH Analogue in Patients with Central Precocious Puberty
por: Kendirci, H. Nur Peltek, et al.
Publicado: (2015)

GnRHa protects the ovarian reserve by reducing endoplasmic reticulum stress during cyclophosphamide-based chemotherapy
por: Li, Xiaolin, et al.
Publicado: (2021)

Gonadotropin-releasing hormone (GnRH) stimulation test before and after GnRH analogue treatment in central precocious puberty; can GnRH test simplify adequately?
por: Yang, You Jean, et al.
Publicado: (2013)

Noonan syndrome: rhGH treatment and PTPN11 mutation
por: Wu, Xian, et al.
Publicado: (2023)

GnRHa for Ovarian Protection and the Association between AMH and Ovarian Function during Adjuvant Chemotherapy for Breast Cancer
por: Zhong, Ying, et al.
Publicado: (2019)

Expression profiles of E/P receptors and fibrosis in GnRHa-treated and -untreated women with different uterine leiomyomas
por: Khan, Khaleque N., et al.
Publicado: (2020)

GnRHa as a treatment for letrozole-resistant recurrent adult granulosa cell tumors: A case report
por: Zhuang, Yuan, et al.
Publicado: (2021)

Effect of recombinant LH supplementation timing on clinical pregnancy outcome in long-acting GnRHa downregulated cycles
por: Huang, Chenyang, et al.
Publicado: (2022)

Just as Tall on Testosterone; a Neutral to Positive Effect on Adult Height of GnRHa and Testosterone in Trans Boys
por: Willemsen, Lieve Anne, et al.
Publicado: (2022)

Leptin and adiponectin levels in girls with central precocious puberty before and during GnRH agonist treatment
por: Yoo, Jae Won, et al.
Publicado: (2016)

THU193 Clinical Usefulness Of Repetitive GnRH Stimulation Test For The Diagnosis Of Central Precocious Puberty
por: Heo, Seung, et al.
Publicado: (2023)

GH Resistance Is a Component of Idiopathic Short Stature: Implications for rhGH Therapy
por: Savage, Martin O., et al.
Publicado: (2021)

Serum aminoterminal proctype natriuretic peptide in girls with idiopathic central precocious puberty during GNRHA treatment
por: Chen, Qiu-li, et al.
Publicado: (2013)

GnRH agonist treatment for idiopathic central precocious puberty can improve final adult height in Chinese girls
por: Ying, Yanqin, et al.
Publicado: (2017)

Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells
por: Luo, Xiaoping, et al.
Publicado: (2003)

Effects of GnRHa treatment during vitellogenesis on the reproductive physiology of thermally challenged female Atlantic salmon (Salmo salar)
por: Anderson, Kelli, et al.
Publicado: (2017)

Pre-treatment with GnRHa or ulipristal acetate prior to laparoscopic and laparotomic myomectomy: A systematic review and meta-analysis
por: de Milliano, Inge, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_aj0u30bf3arf4op9rht28qclg3